Incannex Healthcare Announces 1-for-30 Reverse Stock Split to Regain Nasdaq Compliance

summarizeSummary

Incannex Healthcare Inc. announced a 1-for-30 reverse stock split, effective February 26, 2026, to boost its share price and regain compliance with Nasdaq listing requirements.

check_boxKey Events · Corporate Governance and Compliance · IXHL

• 1-for-30 Reverse Stock Split Approved

  The company filed an amendment to its certificate of incorporation to effect a 1-for-30 reverse stock split, which will become effective on February 26, 2026, at 4:01 p.m. Eastern Time.

• Nasdaq Compliance Objective

  The primary purpose of the reverse stock split is to increase the per-share trading price of the common stock to regain compliance with The Nasdaq Capital Market's minimum bid price requirement for continued listing.

• Share Structure Impact

  The reverse split will reduce the number of outstanding common shares from approximately 358.3 million to about 11.9 million. The total authorized number of shares will not be reduced, potentially increasing future dilution headroom.

• Fractional Share Rounding

  No fractional shares will be issued; stockholders entitled to fractional shares will have them rounded up to the next whole share.

auto_awesomeAnalysis · IXHL · Life Sciences

Incannex Healthcare Inc. has implemented a 1-for-30 reverse stock split, a significant corporate action primarily aimed at increasing its per-share trading price to meet Nasdaq's minimum bid price requirement. While necessary to avoid delisting, reverse stock splits are often viewed negatively by the market as they can signal underlying financial distress or a lack of organic growth. The reduction in outstanding shares from approximately 358 million to 11.9 million, without a corresponding reduction in authorized shares, could increase the potential for future dilution if the company issues new shares. Investors should monitor the stock's performance post-split and the company's ability to maintain Nasdaq compliance.